NEW YORK (GenomeWeb News) – Life Technologies will distribute Aruna Biomedical's human embryonic stem cell-derived neural products, under a non-exclusive, multi-year agreement announced today by Athens, Ga.-based Aruna.

Aruna said that Life Technologies will provide the neural products and will be able to provide customized screening services using Aruna products and technologies. The firm said that other human cellular products may be added to the pact in the future.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.